Document Detail


Adoptive immunotherapy for cancer: harnessing the T cell response.
MedLine Citation:
PMID:  22437939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Immunotherapy based on the adoptive transfer of naturally occurring or gene-engineered T cells can mediate tumour regression in patients with metastatic cancer. Here, we discuss progress in the use of adoptively transferred T cells, focusing on how they can mediate tumour cell eradication. Recent advances include more accurate targeting of antigens expressed by tumours and the associated vasculature, and the successful use of gene engineering to re-target T cells before their transfer into the patient. We also describe how new research has helped to identify the particular T cell subsets that can most effectively promote tumour eradication.
Authors:
Nicholas P Restifo; Mark E Dudley; Steven A Rosenberg
Related Documents :
9686309 - Immunohistochemical assessment of prostaglandin h-synthase in bovine endometrial biopsy...
20701979 - Expression and role of interleukin-23 in human endometrium throughout the menstrual cyc...
15855299 - Phytoestrogens modulate prostaglandin production in bovine endometrium: cell type speci...
8270619 - The expression of basic fibroblast growth factor and its receptor in cell lines derived...
16046839 - Whey acidic protein (wap) depresses the proliferation of mouse (mmt) and human (mcf-7) ...
8601589 - The estrogen-dependent c-juner protein causes a reversible loss of mammary epithelial c...
2493159 - Ubiquitous expression of sevenless: position-dependent specification of cell fate.
15838659 - Single nucleotide polymorphisms modify the transporter activity of abcg2.
10476899 - Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural; Review     Date:  2012-03-22
Journal Detail:
Title:  Nature reviews. Immunology     Volume:  12     ISSN:  1474-1741     ISO Abbreviation:  Nat. Rev. Immunol.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-22     Completed Date:  2012-07-09     Revised Date:  2014-03-18    
Medline Journal Info:
Nlm Unique ID:  101124169     Medline TA:  Nat Rev Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  269-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Genetic Engineering / methods
Humans
Immunotherapy, Adoptive / methods*
Neoplasms / immunology*,  therapy*
T-Lymphocytes / immunology*,  transplantation*
Comments/Corrections
Comment In:
Trends Immunol. 2014 Feb;35(2):47-8   [PMID:  24439426 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Coordinated regulation of myeloid cells by tumours.
Next Document:  Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals.